Bill Detail
H.R. 5256
Congress: 119
Title
340B ACCESS Act
Summary
No summary published on Congress.gov yet — common for recently introduced bills.
Sponsor
Rep. Earl Carter [R-GA-1]
Status
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Status as of Jun 28, 11:56 PM · synced 20h ago
Introduced
2025-09-10
Data source mode: cache
Bill Engagement
340B ACCESS Act
Sponsor
Rep. Earl Carter [R-GA-1]R
Status
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Cosponsors
0D · 1R
Partisan (R only)
LDA engagement
5 orgs · 8 filings
Top: Pharmaceutical Research and Manufactur…
Introduced
2025-09-10
Lobbyists on the case
5 orgs · 85 lobbyists · 8 filings mention H.R. 5256 (340B ACCESS Act) in LDA disclosures.
Top orgs filing
- Pharmaceutical Research and Manufacturers of America3 filings · 26 lobs
- American Hospital Association2 filings · 30 lobs
- Johnson & Johnson Services, Inc.1 filing · 16 lobs
- Biotechnology Innovation Organization1 filing · 12 lobs
- Chronic Care Policy Alliance1 filing · 1 lob
Lobbyists on this bill
- Teresa Bill2026 Q1
- Elenora Connors2026 Q1
- Catherine Douglas2026 Q1
- Bart Forsyth2026 Q1
- Jake Freed2026 Q1Pharmaceutical Research and Manufacturers of America · Cong. Affairs Specialist - FDA; Leg. Asst., Leg. Aide/Press Asst., Staff Asst., District Field Re…
- Kelly Goldberg2026 Q1
- Judith Haron2026 Q1
- Lauren Jee2026 Q1
+ 77 more